Article

Proteomic and metabolic characterization of a Candida albicans mutant resistant to the antimicrobial peptide MUC7 12-mer

Department of Oral Biology, University at Buffalo, the State University of New York, Buffalo, NY 14214, USA.
FEMS Immunology & Medical Microbiology (Impact Factor: 2.55). 09/2008; 54(1):80-91. DOI: 10.1111/j.1574-695X.2008.00450.x
Source: PubMed

ABSTRACT MUC7 12-mer is a cationic peptide derived from the N-terminal portion of human mucin MUC7, exhibiting potent antibacterial and antifungal properties. To advance our knowledge regarding the mechanisms of action of MUC7 peptide against an opportunistic fungal pathogen Candida albicans, we sought to develop and characterize mutant(s) resistant to this peptide. One of the selected mutants, designated #37, was much less susceptible to the MUC7 12-mer in a killing assay than the parental strain (ED(50)>40 vs. c. 6 microM, respectively). Difference gel electrophoresis (DIGE) analysis of the mutant revealed elevation of several glycolytic enzymes. The mutant also exhibited lowered ATP contents along with a relatively lower rate of oxygen consumption, as well as inability to grow on nonfermentable carbon sources. These properties are likely to be associated with changes in metabolic regulation, rather than lack of functional mitochondria, as determined by rhodamine 123 staining. Analysis of interaction between fluorescently labeled peptide and cells of both strains revealed that resistance of the mutant #37 is associated with changes in the process of transition between surface-bound state of the peptide to its internalization marking cell death.

0 Followers
 · 
48 Views
  • Source
    • "The authors speculated that the impaired mitochondrial respiration leads to a decrease of the endogenous ROS level and as a result, to higher drug resistance. Comparable changes in the primary metabolism were also observed in a C. albicans mutant resistance to the human antimicrobial peptide MUC7 12-mer (Lis and Bobek, 2008). The application of fluconazole combined with the alkaloid berberine exerted a synergistic action against clinical, fluconazole-resistant C. albicans strains (Xu et al., 2009). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Both fungi Candida albicans and Aspergillus fumigatus can cause a number of life-threatening systemic infections in humans. The commensal yeast C. albicans is one of the main causes of nosocomial fungal infectious diseases, whereas the filamentous fungus A. fumigatus has become one of the most prevalent airborne fungal pathogens. Early diagnosis of these fungal infections is challenging, only a limited number of antifungals for treatment are available, and the molecular details of pathogenicity are hardly understood. The completion of both the A. fumigatus and C. albicans genome sequence provides the opportunity to improve diagnosis, to define new drug targets, to understand the functions of many uncharacterised proteins, and to study protein regulation on a global scale. With the application of proteomic tools, particularly two-dimensional gel electrophoresis and LC/MS-based methods, a comprehensive overview about the proteins of A. fumigatus and C. albicans present or induced during environmental changes and stress conditions has been obtained in the past 5 years. However, for the discovery of further putative virulence determinants, more sensitive and targeted proteomic methods have to be applied. Here, we review the recent proteome data generated for A. fumigatus and C. albicans that are related to factors required for pathogenicity.
    International journal of medical microbiology: IJMM 06/2011; 301(5):368-77. DOI:10.1016/j.ijmm.2011.04.001 · 3.42 Impact Factor
  • Source
    • "Our earlier results have shown that MUC7 12-mer binds to the surface of C. albicans cells where it accumulates and then, in a concentration-dependent, all-or-none manner breaks membrane integrity leading to an influx of peptide molecules and immediate cell death (Lis and Bobek 2008). One can envision a scenario where the peptide interacting with the surface of plasma membrane imposes a stress perceived by the cell as similar to other environmental cues triggering calcium response. "
    [Show abstract] [Hide abstract]
    ABSTRACT: MUC7 12-mer is a cationic antimicrobial peptide derived from the N-terminal region of human low-molecular-weight salivary mucin. In order to gain new insights into the modes of action of the 12-mer against opportunistic fungal pathogen Candida albicans, we examined changes in the gene expression profile of C. albicans upon exposure to this peptide. Cells at an early logarithmic phase were exposed to 6 muM peptide and grown until an OD(600 nm) of approximately 0.4 was reached. Changes in gene expression were determined by microarray analysis and showed that 19 out of the total of 531 genes, whose expression was elevated in response to the peptide, are regulated by the calcium/calcineurin signalling pathway. Inactivation of this pathway by deletions, or by FK506, caused hypersensitivity to the peptide, demonstrating the importance of this pathway to the defense of C. albicans against the MUC7 peptide. Other differentially expressed genes that were detected include those encoding subunits of proteasome, and genes involved in cell stress, iron metabolism, cell wall maintenance and small-molecule transport. The presented results suggest that the calcium/calcineurin signalling pathway plays a role in the adaptation of C. albicans to the MUC7 antimicrobial peptide.
    FEMS Yeast Research 08/2010; 10(5):579-86. DOI:10.1111/j.1567-1364.2010.00638.x · 2.44 Impact Factor
  • Source
    • "Although not widely used, proteomic methodologies contribute towards determining antimicrobial resistance mechanism(s) and other cell metabolic alterations through the capacity to analyze overall changes in bacteria (Cash, 2000). The pattern of protein species related to antimicrobial resistance has been researched in a variety of microorganisms and with different antimicrobial agents (Andrade et al., 2008; Bore et al., 2007; Cash et al., 1999; Coldham and Woodward, 2004; Diniz et al., 2004; Lis and Bobek, 2008; Mcatee et al., 2001; Pieper et al., 2006; Xu et al., 2006; Yoo et al., 2007). "
    [Show abstract] [Hide abstract]
    ABSTRACT: The worldwide emergence of antibiotic-resistant bacteria poses a serious threat to human health. In addition to the difficulties in controlling infectious diseases, the phenotype of resistance can generate metabolic changes which, in turn, can interfere with host-pathogen interactions. The aim of the present study was to identify changes in the subproteome of a laboratory-derived piperacillin/tazobactam-resistant strain of Escherichia coli (minimal inhibitory concentration [MIC] = 128 mg/L) as compared with its susceptible wild-type strain E. coli ATCC 25922 (MIC = 2 mg/L) using 2-D fluorescence difference gel electrophoresis (2D-DIGE) followed by matrix-assisted laser desorption/ionization time-of-flight/time-of-flight (MALDI-TOF/TOF MS). In the resistant strain, a total of 12 protein species were increased in abundance relative to the wild-type strain, including those related to bacterial virulence, antibiotic resistance and DNA protection during stress. Fourteen proteins were increased in abundance in the wild-type strain compared to the resistant strain, including those involved in glycolysis, protein biosynthesis, pentose-phosphate shunt, amino acid transport, cell division and oxidative stress response. In conclusion, our data show overall changes in the subproteome of the piperacillin/tazobactam-resistant strain, reporting for the first time the potential role of a multidrug efflux pump system in E. coli resistance to piperacillin/tazobactam.
    Research in Microbiology 04/2010; 161(4):268-75. DOI:10.1016/j.resmic.2010.03.006 · 2.83 Impact Factor
Show more

Preview

Download
1 Download